MMP9 and Stroke: As active MMP-9 cleaves a variety of chemokines8 and cytokines9–11, and triggers signaling through various transmembrane proteins35, the BR therapy might reduce the cascade inflammatory responses in stroke through reduced levels of MMP-9 in blood (Fig. 7).